AI Insight
Vasomotor symptoms, including hot flashes and night sweats, are among the most common and disruptive menopause symptoms, affecting nearly 40% of women during perimenopause. Veoza represents a new pharmaceutical approach to managing these symptoms, operating through a different mechanism than traditional hormone replacement therapy. The article examines how Veoza functions and distinguishes its mode of action from conventional hormonal treatments.
Why it matters
This information is relevant for the significant proportion of perimenopausal and menopausal women seeking alternatives to hormone therapy for managing vasomotor symptoms. Understanding the differences between treatment options enables more informed decision-making between patients and healthcare providers regarding menopause symptom management.
Understand the Science
Hot flashes and night sweats—collectively called vasomotor symptoms—are among the most common and disruptive symptoms of menopause. They affect almost 40% of women in the lead-up to menopause, known as perimenopause.
Source: How does the menopause drug Veoza work? And how is it different from hormone therapy?